Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Adapting dried blood spot sampling for an anti-therapeutic antibody immunogenicity assay.

Xiang Y, Welch M, Amaravadi L, Stebbins C.

J Immunol Methods. 2013 Jul 31;393(1-2):53-60. doi: 10.1016/j.jim.2013.04.006. Epub 2013 Apr 18.

PMID:
23603618
2.

Application of automated serial blood sampling and dried blood spot technique with liquid chromatography-tandem mass spectrometry for pharmacokinetic studies in mice.

Wong P, Pham R, Whitely C, Soto M, Salyers K, James C, Bruenner BA.

J Pharm Biomed Anal. 2011 Nov 1;56(3):604-8. doi: 10.1016/j.jpba.2011.06.022. Epub 2011 Jul 1.

PMID:
21784595
3.

Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls.

Edelbroek PM, van der Heijden J, Stolk LM.

Ther Drug Monit. 2009 Jun;31(3):327-36. doi: 10.1097/FTD.0b013e31819e91ce. Review.

PMID:
19349929
4.

Quantitative determination of atenolol in dried blood spot samples by LC-HRMS: a potential method for assessing medication adherence.

Lawson G, Cocks E, Tanna S.

J Chromatogr B Analyt Technol Biomed Life Sci. 2012 May 15;897:72-9. doi: 10.1016/j.jchromb.2012.04.013. Epub 2012 Apr 16.

PMID:
22552005
5.

Dried blood spot assay for the quantification of phenytoin using Liquid Chromatography-Mass Spectrometry.

Villanelli F, Giocaliere E, Malvagia S, Rosati A, Forni G, Funghini S, Shokry E, Ombrone D, Della Bona ML, Guerrini R, la Marca G.

Clin Chim Acta. 2015 Feb 2;440:31-5. doi: 10.1016/j.cca.2014.11.007. Epub 2014 Nov 12.

PMID:
25447695
6.

Dried blood spots in toxicology: from the cradle to the grave?

Stove CP, Ingels AS, De Kesel PM, Lambert WE.

Crit Rev Toxicol. 2012 Mar;42(3):230-43. doi: 10.3109/10408444.2011.650790. Review.

PMID:
22348353
7.

Therapeutic drug monitoring by dried blood spot: progress to date and future directions.

Wilhelm AJ, den Burger JC, Swart EL.

Clin Pharmacokinet. 2014 Nov;53(11):961-73. doi: 10.1007/s40262-014-0177-7. Review.

8.

Perforated dried blood spot accurate microsampling: the concept and its applications in toxicokinetic sample collection.

Li F, Ploch S, Fast D, Michael S.

J Mass Spectrom. 2012 May;47(5):655-67. doi: 10.1002/jms.3015.

PMID:
22576879
9.

Dried blood spot testing: a novel approach for the therapeutic drug monitoring of ziprasidone-treated patients.

Mercolini L, Mandrioli R, Protti M, Conca A, Albers LJ, Raggi MA.

Bioanalysis. 2014 Jun;6(11):1487-95. doi: 10.4155/bio.14.3.

PMID:
25046049
10.

Dried blood spot analysis of an iron chelator--deferasirox and its potential application to therapeutic drug monitoring.

Nirogi R, Ajjala DR, Kandikere V, Aleti R, Srikakolapu S, Vurimindi H.

J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Oct 15;907:65-73. doi: 10.1016/j.jchromb.2012.08.036. Epub 2012 Sep 2.

PMID:
23036906
11.

Dried blood spots: a new tool for tuberculosis treatment optimization.

Vu DH, Alffenaar JW, Edelbroek PM, Brouwers JR, Uges DR.

Curr Pharm Des. 2011;17(27):2931-9. Review.

PMID:
21834763
12.

Evaluation of dried blood spot (DBS) technology versus plasma analysis for the determination of MK-1775 by HILIC-MS/MS in support of clinical studies.

Xu Y, Fang W, Zeng W, Leijen S, Woolf EJ.

Anal Bioanal Chem. 2012 Dec;404(10):3037-48. doi: 10.1007/s00216-012-6440-6. Epub 2012 Oct 26.

PMID:
23099526
13.

Multiplexed quantitation of endogenous proteins in dried blood spots by multiple reaction monitoring-mass spectrometry.

Chambers AG, Percy AJ, Yang J, Camenzind AG, Borchers CH.

Mol Cell Proteomics. 2013 Mar;12(3):781-91. doi: 10.1074/mcp.M112.022442. Epub 2012 Dec 7.

14.

Investigations into the environmental conditions experienced during ambient sample transport: impact to dried blood spot sample shipments.

Bowen CL, Dopson W, Kemp DC, Lewis M, Lad R, Overvold C.

Bioanalysis. 2011 Jul;3(14):1625-33. doi: 10.4155/bio.11.128.

PMID:
21756095
15.

A modified serial blood sampling technique and utility of dried-blood spot technique in estimation of blood concentration: application in mouse pharmacokinetics.

Kurawattimath V, Pocha K, Mariappan TT, Trivedi RK, Mandlekar S.

Eur J Drug Metab Pharmacokinet. 2012 Mar;37(1):23-30. doi: 10.1007/s13318-011-0066-5. Epub 2011 Sep 25. Erratum in: Eur J Drug Metab Pharmacokinet. 2011 Dec;36(4):263.

PMID:
21948266
16.

Merck's perspective on the implementation of dried blood spot technology in clinical drug development - why, when and how.

Xu Y, Woolf EJ, Agrawal NG, Kothare P, Pucci V, Bateman KP.

Bioanalysis. 2013 Feb;5(3):341-50. doi: 10.4155/bio.12.321.

PMID:
23394700
17.

Clinical validation of dried blood spot sampling in therapeutic drug monitoring of ciclosporin A in allogeneic stem cell transplant recipients: direct comparison between capillary and venous sampling.

Wilhelm AJ, Klijn A, den Burger JC, Visser OJ, Veldkamp AI, Janssen JJ, Swart EL.

Ther Drug Monit. 2013 Feb;35(1):92-5. doi: 10.1097/FTD.0b013e31827d76ce.

PMID:
23296096
18.

Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules.

Li W, Tse FL.

Biomed Chromatogr. 2010 Jan;24(1):49-65. doi: 10.1002/bmc.1367. Review.

PMID:
20017122
19.
20.

Dried blood spot analysis for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis.

Vu DH, Bolhuis MS, Koster RA, Greijdanus B, de Lange WC, van Altena R, Brouwers JR, Uges DR, Alffenaar JW.

Antimicrob Agents Chemother. 2012 Nov;56(11):5758-63. doi: 10.1128/AAC.01054-12. Epub 2012 Aug 27.

Supplemental Content

Support Center